GeneScience Pharmaceutical Co, Ltd and its CEO have pleaded guilty to selling Jintropin, a human growth hormone used to build muscle, without the approval of the Food and Drug Administration.U.S. v. GeneScience Pharmaceutical, Co., Ltd., No. 10-144-02 (U.S. Dist. Ct., D.R.I., plea entered October 1, 2010). The defendants agreed to pay $4.5 million as a substitute asset to satisfy the forfeiture allegations of the criminal information and will contribute $3 million to create a “Clean Competition Fund” to satisfy a community service obligation. CEO Jin Lei was sentenced to five years’ probation and will not be permitted to sell drugs to U.S. customers during that time without the approval of the Department of Health and Human Services. According to a news source, GeneScience is believed to be responsible for most of the human growth hormone smuggled into the United States. See The Associated Press, October 7, 2010.